Katerina Kechris
Concepts (498)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metabolomics | 16 | 2024 | 678 | 2.990 |
Why?
| | Pulmonary Disease, Chronic Obstructive | 20 | 2024 | 1040 | 2.910 |
Why?
| | DNA Methylation | 21 | 2025 | 643 | 2.580 |
Why?
| | Algorithms | 14 | 2025 | 1704 | 2.200 |
Why?
| | Computational Biology | 9 | 2025 | 644 | 2.130 |
Why?
| | Genome-Wide Association Study | 11 | 2024 | 1431 | 2.120 |
Why?
| | Software | 13 | 2024 | 665 | 2.030 |
Why?
| | Gene Expression Profiling | 19 | 2021 | 1774 | 1.810 |
Why?
| | Sequence Analysis, RNA | 9 | 2021 | 452 | 1.760 |
Why?
| | Bayes Theorem | 10 | 2023 | 405 | 1.750 |
Why?
| | MicroRNAs | 10 | 2023 | 692 | 1.660 |
Why?
| | Proteomics | 4 | 2025 | 1111 | 1.630 |
Why?
| | Mass Spectrometry | 6 | 2022 | 739 | 1.470 |
Why?
| | High-Throughput Nucleotide Sequencing | 5 | 2021 | 539 | 1.470 |
Why?
| | Genomics | 7 | 2025 | 795 | 1.420 |
Why?
| | Quantitative Trait Loci | 15 | 2024 | 380 | 1.360 |
Why?
| | Gene Regulatory Networks | 6 | 2025 | 305 | 1.330 |
Why?
| | Data Interpretation, Statistical | 5 | 2020 | 363 | 1.220 |
Why?
| | Prenatal Exposure Delayed Effects | 13 | 2025 | 605 | 1.200 |
Why?
| | Smoking | 9 | 2025 | 1627 | 1.180 |
Why?
| | Polymorphism, Single Nucleotide | 11 | 2024 | 2189 | 1.150 |
Why?
| | Gene Expression Regulation | 12 | 2022 | 2607 | 1.140 |
Why?
| | Models, Genetic | 7 | 2019 | 600 | 1.080 |
Why?
| | Phenotype | 21 | 2024 | 3196 | 1.000 |
Why?
| | Oligonucleotide Array Sequence Analysis | 6 | 2021 | 767 | 0.930 |
Why?
| | Adiposity | 10 | 2024 | 518 | 0.910 |
Why?
| | Brain | 9 | 2024 | 2668 | 0.870 |
Why?
| | Gene Expression | 10 | 2021 | 1502 | 0.850 |
Why?
| | Transcriptome | 9 | 2021 | 971 | 0.800 |
Why?
| | Islets of Langerhans | 7 | 2025 | 803 | 0.790 |
Why?
| | Metabolome | 5 | 2024 | 350 | 0.780 |
Why?
| | Computer Simulation | 9 | 2025 | 978 | 0.770 |
Why?
| | Databases, Factual | 6 | 2021 | 1357 | 0.760 |
Why?
| | Emphysema | 4 | 2023 | 106 | 0.730 |
Why?
| | Models, Statistical | 5 | 2020 | 669 | 0.710 |
Why?
| | Propensity Score | 1 | 2023 | 294 | 0.710 |
Why?
| | Ethanol | 5 | 2020 | 608 | 0.680 |
Why?
| | Autoimmunity | 9 | 2025 | 908 | 0.680 |
Why?
| | Maternal Exposure | 6 | 2024 | 190 | 0.660 |
Why?
| | Conserved Sequence | 3 | 2009 | 239 | 0.660 |
Why?
| | Pediatric Obesity | 7 | 2024 | 601 | 0.660 |
Why?
| | Diabetes Mellitus, Type 1 | 12 | 2025 | 3715 | 0.650 |
Why?
| | Machine Learning | 2 | 2024 | 493 | 0.650 |
Why?
| | Pulmonary Emphysema | 6 | 2023 | 288 | 0.630 |
Why?
| | User-Computer Interface | 1 | 2020 | 159 | 0.630 |
Why?
| | Humans | 96 | 2025 | 137585 | 0.620 |
Why?
| | Epigenesis, Genetic | 12 | 2024 | 660 | 0.610 |
Why?
| | Fluorocarbons | 4 | 2023 | 117 | 0.590 |
Why?
| | RNA | 4 | 2021 | 921 | 0.590 |
Why?
| | Biomarkers | 19 | 2024 | 4149 | 0.580 |
Why?
| | Health Status | 1 | 2023 | 792 | 0.560 |
Why?
| | Fetal Blood | 10 | 2024 | 327 | 0.550 |
Why?
| | Linear Models | 4 | 2019 | 849 | 0.520 |
Why?
| | ROC Curve | 5 | 2020 | 554 | 0.510 |
Why?
| | Models, Theoretical | 1 | 2020 | 578 | 0.500 |
Why?
| | Hypnotics and Sedatives | 1 | 2018 | 200 | 0.490 |
Why?
| | Genetic Predisposition to Disease | 11 | 2023 | 2426 | 0.490 |
Why?
| | Alcoholism | 3 | 2020 | 807 | 0.490 |
Why?
| | Female | 63 | 2025 | 73304 | 0.480 |
Why?
| | Animals | 34 | 2023 | 36940 | 0.480 |
Why?
| | Glycosphingolipids | 1 | 2015 | 7 | 0.470 |
Why?
| | Drosophila | 3 | 2010 | 154 | 0.450 |
Why?
| | CpG Islands | 7 | 2024 | 157 | 0.450 |
Why?
| | Environmental Pollutants | 3 | 2023 | 159 | 0.440 |
Why?
| | Placenta | 5 | 2023 | 750 | 0.430 |
Why?
| | Pregnancy | 22 | 2025 | 6763 | 0.430 |
Why?
| | Interleukin-16 | 1 | 2013 | 6 | 0.430 |
Why?
| | Nitrogenase | 2 | 2013 | 9 | 0.420 |
Why?
| | Case-Control Studies | 14 | 2023 | 3556 | 0.420 |
Why?
| | Schistosomiasis japonica | 3 | 2022 | 32 | 0.400 |
Why?
| | Transcription, Genetic | 3 | 2018 | 1457 | 0.400 |
Why?
| | Smoking Cessation | 1 | 2017 | 442 | 0.400 |
Why?
| | Mice | 19 | 2022 | 17787 | 0.400 |
Why?
| | Markov Chains | 2 | 2020 | 126 | 0.400 |
Why?
| | Multivariate Analysis | 2 | 2013 | 1509 | 0.390 |
Why?
| | DNA | 3 | 2019 | 1459 | 0.380 |
Why?
| | Sample Size | 3 | 2023 | 125 | 0.380 |
Why?
| | RNA, Messenger | 7 | 2023 | 2833 | 0.380 |
Why?
| | Genotype | 6 | 2020 | 1916 | 0.380 |
Why?
| | Male | 49 | 2025 | 67762 | 0.380 |
Why?
| | Diabetes, Gestational | 3 | 2023 | 318 | 0.370 |
Why?
| | Transcription Factors | 6 | 2024 | 1719 | 0.370 |
Why?
| | Phylogeny | 2 | 2013 | 904 | 0.360 |
Why?
| | Lipid Metabolism | 4 | 2024 | 518 | 0.360 |
Why?
| | Schistosoma japonicum | 2 | 2022 | 31 | 0.360 |
Why?
| | Support Vector Machine | 2 | 2021 | 38 | 0.340 |
Why?
| | Area Under Curve | 3 | 2020 | 314 | 0.340 |
Why?
| | Lung | 5 | 2023 | 4060 | 0.340 |
Why?
| | Bias | 2 | 2022 | 218 | 0.340 |
Why?
| | Child | 28 | 2025 | 21935 | 0.330 |
Why?
| | Genome, Human | 3 | 2019 | 425 | 0.330 |
Why?
| | Molybdoferredoxin | 1 | 2009 | 12 | 0.320 |
Why?
| | Binding Sites | 5 | 2021 | 1303 | 0.320 |
Why?
| | Gastrointestinal Tract | 2 | 2022 | 195 | 0.310 |
Why?
| | Oxidoreductases | 1 | 2009 | 92 | 0.300 |
Why?
| | Infant, Newborn | 15 | 2024 | 6079 | 0.290 |
Why?
| | Insulin | 6 | 2023 | 2409 | 0.290 |
Why?
| | Child, Preschool | 17 | 2024 | 11074 | 0.290 |
Why?
| | Mycobacterium tuberculosis | 3 | 2016 | 314 | 0.290 |
Why?
| | Adiponectin | 2 | 2024 | 244 | 0.290 |
Why?
| | Signal Transduction | 7 | 2020 | 5079 | 0.280 |
Why?
| | Disease Progression | 5 | 2024 | 2757 | 0.280 |
Why?
| | Exons | 1 | 2008 | 355 | 0.270 |
Why?
| | Autoantibodies | 4 | 2024 | 1496 | 0.270 |
Why?
| | Bronchoalveolar Lavage Fluid | 2 | 2022 | 652 | 0.260 |
Why?
| | Insulin-Like Growth Factor I | 2 | 2021 | 319 | 0.260 |
Why?
| | Leukocytes, Mononuclear | 3 | 2015 | 558 | 0.260 |
Why?
| | HIV-1 | 3 | 2022 | 864 | 0.260 |
Why?
| | Cluster Analysis | 3 | 2024 | 499 | 0.260 |
Why?
| | Alternative Splicing | 1 | 2008 | 229 | 0.260 |
Why?
| | Cohort Studies | 10 | 2023 | 5742 | 0.250 |
Why?
| | Alcohol Drinking | 5 | 2014 | 828 | 0.250 |
Why?
| | Mice, Inbred DBA | 2 | 2019 | 200 | 0.250 |
Why?
| | HIV Infections | 4 | 2022 | 2836 | 0.240 |
Why?
| | Environmental Exposure | 2 | 2020 | 579 | 0.230 |
Why?
| | Alkanesulfonic Acids | 2 | 2023 | 41 | 0.230 |
Why?
| | Genome | 3 | 2013 | 300 | 0.230 |
Why?
| | Tuberculosis | 2 | 2020 | 279 | 0.230 |
Why?
| | Middle Aged | 18 | 2024 | 33479 | 0.230 |
Why?
| | Principal Component Analysis | 2 | 2023 | 195 | 0.230 |
Why?
| | Soot | 1 | 2024 | 26 | 0.220 |
Why?
| | Tuberculosis, Pulmonary | 2 | 2016 | 141 | 0.220 |
Why?
| | Mice, Inbred Strains | 4 | 2020 | 409 | 0.220 |
Why?
| | Oxylipins | 2 | 2023 | 40 | 0.220 |
Why?
| | Quantitative Trait, Heritable | 3 | 2017 | 125 | 0.220 |
Why?
| | Prospective Studies | 9 | 2023 | 7604 | 0.220 |
Why?
| | Seroconversion | 2 | 2021 | 46 | 0.220 |
Why?
| | Carnitine O-Palmitoyltransferase | 2 | 2021 | 46 | 0.210 |
Why?
| | Aged | 13 | 2024 | 23961 | 0.210 |
Why?
| | Melanocytes | 2 | 2015 | 65 | 0.210 |
Why?
| | Severity of Illness Index | 5 | 2021 | 2828 | 0.210 |
Why?
| | Body Mass Index | 5 | 2024 | 2389 | 0.210 |
Why?
| | Reproducibility of Results | 3 | 2021 | 3284 | 0.210 |
Why?
| | Mice, Inbred C57BL | 5 | 2019 | 5757 | 0.210 |
Why?
| | Infant | 12 | 2024 | 9465 | 0.200 |
Why?
| | Sequence Analysis, DNA | 2 | 2019 | 812 | 0.200 |
Why?
| | Genetic Association Studies | 3 | 2020 | 377 | 0.200 |
Why?
| | Diet | 2 | 2021 | 1278 | 0.200 |
Why?
| | Genetic Variation | 3 | 2024 | 991 | 0.200 |
Why?
| | Somatic Hypermutation, Immunoglobulin | 1 | 2022 | 19 | 0.190 |
Why?
| | Birth Weight | 3 | 2023 | 516 | 0.190 |
Why?
| | Bone Morphogenetic Proteins | 1 | 2023 | 135 | 0.190 |
Why?
| | Phospholipids | 2 | 2021 | 223 | 0.190 |
Why?
| | Mothers | 3 | 2023 | 754 | 0.190 |
Why?
| | Schistosomiasis | 1 | 2022 | 47 | 0.190 |
Why?
| | Breast Neoplasms | 3 | 2019 | 2253 | 0.180 |
Why?
| | Epidemiologic Studies | 1 | 2021 | 72 | 0.180 |
Why?
| | Selection Bias | 1 | 2021 | 37 | 0.180 |
Why?
| | Endemic Diseases | 1 | 2021 | 32 | 0.180 |
Why?
| | Viral Nonstructural Proteins | 1 | 2021 | 65 | 0.180 |
Why?
| | Receptor for Advanced Glycation End Products | 1 | 2021 | 33 | 0.180 |
Why?
| | Cloud Computing | 1 | 2021 | 7 | 0.180 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2021 | 9 | 0.180 |
Why?
| | Mitogen-Activated Protein Kinase 9 | 1 | 2021 | 18 | 0.180 |
Why?
| | Air Pollutants | 2 | 2024 | 430 | 0.180 |
Why?
| | Central Nervous System Depressants | 2 | 2012 | 85 | 0.170 |
Why?
| | Immunoglobulin A | 1 | 2022 | 211 | 0.170 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2021 | 42 | 0.170 |
Why?
| | Sensitivity and Specificity | 2 | 2017 | 1946 | 0.170 |
Why?
| | Genome, Viral | 1 | 2021 | 144 | 0.170 |
Why?
| | Normal Distribution | 2 | 2018 | 21 | 0.170 |
Why?
| | Spike Glycoprotein, Coronavirus | 1 | 2021 | 109 | 0.170 |
Why?
| | Polyadenylation | 1 | 2021 | 42 | 0.170 |
Why?
| | Mutation | 3 | 2021 | 3958 | 0.170 |
Why?
| | Adult | 20 | 2024 | 37929 | 0.170 |
Why?
| | Population Dynamics | 1 | 2021 | 151 | 0.170 |
Why?
| | Biostatistics | 1 | 2020 | 18 | 0.170 |
Why?
| | Probability | 1 | 2021 | 304 | 0.170 |
Why?
| | Travel | 1 | 2021 | 130 | 0.170 |
Why?
| | Drug Tolerance | 1 | 2020 | 105 | 0.170 |
Why?
| | Interferon-beta | 1 | 2020 | 92 | 0.170 |
Why?
| | Monte Carlo Method | 1 | 2020 | 148 | 0.160 |
Why?
| | Discriminant Analysis | 1 | 2020 | 37 | 0.160 |
Why?
| | Smoke | 2 | 2023 | 141 | 0.160 |
Why?
| | Adolescent | 11 | 2025 | 21513 | 0.160 |
Why?
| | Premature Birth | 1 | 2023 | 333 | 0.160 |
Why?
| | Least-Squares Analysis | 1 | 2020 | 79 | 0.160 |
Why?
| | Whole Genome Sequencing | 1 | 2021 | 160 | 0.160 |
Why?
| | Longitudinal Studies | 6 | 2025 | 2844 | 0.160 |
Why?
| | Infant Nutritional Physiological Phenomena | 1 | 2021 | 146 | 0.160 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2021 | 283 | 0.160 |
Why?
| | Decision Trees | 1 | 2020 | 93 | 0.160 |
Why?
| | AMP-Activated Protein Kinases | 2 | 2020 | 197 | 0.160 |
Why?
| | Risk Factors | 8 | 2024 | 10388 | 0.160 |
Why?
| | Interferon-alpha | 1 | 2020 | 198 | 0.160 |
Why?
| | alpha-Macroglobulins | 1 | 2019 | 24 | 0.150 |
Why?
| | Liver | 2 | 2019 | 1943 | 0.150 |
Why?
| | Sex Characteristics | 2 | 2023 | 762 | 0.150 |
Why?
| | Child Nutritional Physiological Phenomena | 1 | 2019 | 108 | 0.150 |
Why?
| | Atherosclerosis | 1 | 2023 | 415 | 0.150 |
Why?
| | Rats | 4 | 2023 | 5647 | 0.150 |
Why?
| | Base Sequence | 3 | 2021 | 2181 | 0.150 |
Why?
| | Air Pollution | 1 | 2022 | 316 | 0.150 |
Why?
| | Proteome | 1 | 2023 | 472 | 0.150 |
Why?
| | Hypertension, Pregnancy-Induced | 1 | 2019 | 69 | 0.150 |
Why?
| | GABA-A Receptor Antagonists | 1 | 2018 | 19 | 0.150 |
Why?
| | Reflex, Righting | 1 | 2018 | 15 | 0.150 |
Why?
| | Autism Spectrum Disorder | 1 | 2023 | 395 | 0.140 |
Why?
| | Marijuana Use | 1 | 2022 | 206 | 0.140 |
Why?
| | Antiviral Agents | 2 | 2021 | 744 | 0.140 |
Why?
| | Papillomavirus E7 Proteins | 1 | 2017 | 11 | 0.140 |
Why?
| | Receptor, Insulin | 1 | 2017 | 105 | 0.140 |
Why?
| | Respiratory Mucosa | 1 | 2020 | 321 | 0.140 |
Why?
| | Dendritic Cells | 1 | 2020 | 483 | 0.130 |
Why?
| | Epigenomics | 2 | 2018 | 115 | 0.130 |
Why?
| | Alcohol-Related Disorders | 1 | 2018 | 122 | 0.130 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2020 | 279 | 0.130 |
Why?
| | Rural Population | 1 | 2021 | 563 | 0.130 |
Why?
| | Receptors, GABA-A | 1 | 2018 | 142 | 0.130 |
Why?
| | Otitis Media | 1 | 2019 | 165 | 0.130 |
Why?
| | Down-Regulation | 1 | 2019 | 657 | 0.130 |
Why?
| | Pregnancy Outcome | 1 | 2019 | 416 | 0.130 |
Why?
| | Chemokines | 1 | 2017 | 228 | 0.130 |
Why?
| | Alleles | 1 | 2019 | 891 | 0.130 |
Why?
| | Longevity | 1 | 2017 | 165 | 0.130 |
Why?
| | Receptors, N-Methyl-D-Aspartate | 1 | 2018 | 219 | 0.130 |
Why?
| | Predictive Value of Tests | 3 | 2017 | 2031 | 0.120 |
Why?
| | Gene-Environment Interaction | 1 | 2017 | 192 | 0.120 |
Why?
| | DNA-Binding Proteins | 3 | 2019 | 1502 | 0.120 |
Why?
| | Biomedical Research | 2 | 2020 | 692 | 0.120 |
Why?
| | Keratinocytes | 1 | 2017 | 249 | 0.120 |
Why?
| | Age Factors | 2 | 2021 | 3295 | 0.120 |
Why?
| | High Fructose Corn Syrup | 1 | 2015 | 8 | 0.120 |
Why?
| | Histocompatibility Antigens Class I | 1 | 2017 | 203 | 0.120 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2018 | 188 | 0.120 |
Why?
| | Corpus Luteum | 1 | 2015 | 20 | 0.120 |
Why?
| | Plasma | 1 | 2017 | 212 | 0.120 |
Why?
| | Databases, Genetic | 2 | 2021 | 237 | 0.120 |
Why?
| | Granulosa Cells | 1 | 2015 | 33 | 0.120 |
Why?
| | Cell-Derived Microparticles | 1 | 2016 | 71 | 0.120 |
Why?
| | Ultraviolet Therapy | 1 | 2015 | 16 | 0.120 |
Why?
| | Trihexosylceramides | 1 | 2015 | 4 | 0.120 |
Why?
| | Adaptation, Physiological | 2 | 2016 | 553 | 0.120 |
Why?
| | Sphingomyelins | 1 | 2015 | 33 | 0.120 |
Why?
| | Tobacco Products | 1 | 2016 | 138 | 0.120 |
Why?
| | Vitiligo | 1 | 2015 | 42 | 0.120 |
Why?
| | Microarray Analysis | 2 | 2012 | 117 | 0.110 |
Why?
| | Obesity | 4 | 2023 | 2992 | 0.110 |
Why?
| | Infant, Premature | 1 | 2019 | 574 | 0.110 |
Why?
| | Cannabis | 1 | 2022 | 494 | 0.110 |
Why?
| | Tobacco Smoke Pollution | 1 | 2017 | 261 | 0.110 |
Why?
| | Databases, Nucleic Acid | 1 | 2014 | 34 | 0.110 |
Why?
| | Blood Proteins | 1 | 2016 | 252 | 0.110 |
Why?
| | Aged, 80 and over | 8 | 2021 | 7635 | 0.110 |
Why?
| | Hair | 1 | 2015 | 84 | 0.110 |
Why?
| | Child Development | 1 | 2019 | 475 | 0.110 |
Why?
| | Molecular Sequence Data | 2 | 2009 | 2900 | 0.110 |
Why?
| | Fatty Acids | 1 | 2017 | 443 | 0.110 |
Why?
| | Epithelial Cells | 1 | 2020 | 1096 | 0.110 |
Why?
| | Gastrointestinal Microbiome | 1 | 2022 | 697 | 0.110 |
Why?
| | STAT2 Transcription Factor | 1 | 2013 | 3 | 0.110 |
Why?
| | Drug Resistance, Bacterial | 1 | 2015 | 186 | 0.110 |
Why?
| | 3' Untranslated Regions | 1 | 2014 | 145 | 0.110 |
Why?
| | CCCTC-Binding Factor | 1 | 2013 | 14 | 0.110 |
Why?
| | Gangliosides | 1 | 2013 | 20 | 0.100 |
Why?
| | Species Specificity | 2 | 2012 | 585 | 0.100 |
Why?
| | Saccharomyces | 1 | 2013 | 8 | 0.100 |
Why?
| | Caloric Restriction | 1 | 2015 | 124 | 0.100 |
Why?
| | G-Quadruplexes | 1 | 2013 | 19 | 0.100 |
Why?
| | Dietary Fats | 1 | 2015 | 304 | 0.100 |
Why?
| | Myocardium | 1 | 2018 | 1002 | 0.100 |
Why?
| | Antitubercular Agents | 1 | 2015 | 206 | 0.100 |
Why?
| | Choice Behavior | 1 | 2014 | 170 | 0.100 |
Why?
| | Sequence Alignment | 1 | 2013 | 343 | 0.100 |
Why?
| | Microbiota | 1 | 2021 | 762 | 0.100 |
Why?
| | DNA Probes | 1 | 2012 | 60 | 0.100 |
Why?
| | Programming Languages | 1 | 2012 | 26 | 0.100 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2015 | 328 | 0.100 |
Why?
| | Teratogens | 1 | 2012 | 10 | 0.100 |
Why?
| | Tretinoin | 1 | 2013 | 123 | 0.100 |
Why?
| | Heat-Shock Proteins | 1 | 2013 | 143 | 0.100 |
Why?
| | Gene Expression Regulation, Neoplastic | 1 | 2018 | 1396 | 0.100 |
Why?
| | Ultraviolet Rays | 1 | 2015 | 396 | 0.100 |
Why?
| | Proportional Hazards Models | 3 | 2021 | 1266 | 0.090 |
Why?
| | Fetal Alcohol Spectrum Disorders | 1 | 2012 | 34 | 0.090 |
Why?
| | Weight Gain | 1 | 2015 | 519 | 0.090 |
Why?
| | Tomography, X-Ray Computed | 3 | 2021 | 2691 | 0.090 |
Why?
| | Protein Binding | 2 | 2021 | 2224 | 0.090 |
Why?
| | China | 2 | 2022 | 217 | 0.090 |
Why?
| | Regression Analysis | 3 | 2021 | 1024 | 0.090 |
Why?
| | Triglycerides | 2 | 2023 | 524 | 0.090 |
Why?
| | Chromosome Mapping | 3 | 2020 | 523 | 0.090 |
Why?
| | Pain Threshold | 1 | 2010 | 74 | 0.080 |
Why?
| | HLA-DR4 Antigen | 2 | 2021 | 78 | 0.080 |
Why?
| | Stem Cells | 1 | 2015 | 594 | 0.080 |
Why?
| | HLA-DR3 Antigen | 2 | 2021 | 80 | 0.080 |
Why?
| | Body Weight | 1 | 2015 | 985 | 0.080 |
Why?
| | Dysbiosis | 2 | 2022 | 181 | 0.080 |
Why?
| | Gene Expression Regulation, Developmental | 2 | 2012 | 860 | 0.080 |
Why?
| | Repressor Proteins | 1 | 2013 | 427 | 0.080 |
Why?
| | Adrenal Cortex Hormones | 1 | 2013 | 565 | 0.080 |
Why?
| | Young Adult | 7 | 2020 | 13209 | 0.080 |
Why?
| | Asthma | 1 | 2023 | 2295 | 0.080 |
Why?
| | Morphine | 1 | 2010 | 158 | 0.080 |
Why?
| | Cytokines | 1 | 2017 | 2085 | 0.080 |
Why?
| | Amino Acid Sequence | 2 | 2013 | 2139 | 0.080 |
Why?
| | Hedgehog Proteins | 1 | 2010 | 195 | 0.080 |
Why?
| | Internet | 2 | 2010 | 655 | 0.080 |
Why?
| | Analysis of Variance | 1 | 2012 | 1316 | 0.080 |
Why?
| | Polymerase Chain Reaction | 1 | 2012 | 1062 | 0.080 |
Why?
| | Vital Capacity | 2 | 2021 | 311 | 0.080 |
Why?
| | Energy Metabolism | 1 | 2015 | 922 | 0.080 |
Why?
| | Yeasts | 1 | 2008 | 53 | 0.070 |
Why?
| | Drosophila Proteins | 1 | 2010 | 204 | 0.070 |
Why?
| | Spirometry | 2 | 2021 | 281 | 0.070 |
Why?
| | Fasting | 2 | 2023 | 281 | 0.070 |
Why?
| | Synaptic Transmission | 1 | 2010 | 289 | 0.070 |
Why?
| | Food Preferences | 1 | 2009 | 119 | 0.070 |
Why?
| | Gestational Age | 2 | 2023 | 910 | 0.070 |
Why?
| | Glycerophospholipids | 2 | 2018 | 34 | 0.070 |
Why?
| | Forced Expiratory Volume | 2 | 2021 | 531 | 0.070 |
Why?
| | RNA Precursors | 1 | 2008 | 154 | 0.070 |
Why?
| | Enhancer Elements, Genetic | 1 | 2008 | 190 | 0.070 |
Why?
| | Folic Acid | 2 | 2019 | 186 | 0.070 |
Why?
| | Gene Ontology | 2 | 2017 | 53 | 0.070 |
Why?
| | Tandem Mass Spectrometry | 2 | 2021 | 532 | 0.060 |
Why?
| | Phosphorylation | 2 | 2021 | 1759 | 0.060 |
Why?
| | Follow-Up Studies | 3 | 2021 | 5131 | 0.060 |
Why?
| | Uganda | 2 | 2016 | 77 | 0.060 |
Why?
| | Neoplasms | 2 | 2018 | 2671 | 0.060 |
Why?
| | Glucose | 2 | 2023 | 1020 | 0.060 |
Why?
| | Apoptosis | 1 | 2013 | 2553 | 0.050 |
Why?
| | Sputum | 2 | 2016 | 311 | 0.050 |
Why?
| | Alkanesulfonates | 1 | 2023 | 8 | 0.050 |
Why?
| | GTPase-Activating Proteins | 1 | 2023 | 83 | 0.050 |
Why?
| | Carboxylic Acids | 1 | 2023 | 34 | 0.050 |
Why?
| | Adipogenesis | 1 | 2023 | 55 | 0.050 |
Why?
| | Privacy | 1 | 2023 | 42 | 0.050 |
Why?
| | Hypertrophy | 1 | 2023 | 133 | 0.050 |
Why?
| | Cell Proliferation | 3 | 2015 | 2475 | 0.050 |
Why?
| | Models, Neurological | 1 | 2024 | 242 | 0.050 |
Why?
| | Analgesics, Opioid | 1 | 2010 | 1000 | 0.050 |
Why?
| | Schistosoma | 1 | 2022 | 28 | 0.050 |
Why?
| | Snails | 1 | 2022 | 37 | 0.050 |
Why?
| | Pneumonia | 2 | 2020 | 639 | 0.050 |
Why?
| | Cell Differentiation | 2 | 2023 | 1991 | 0.050 |
Why?
| | Protein Conformation, beta-Strand | 1 | 2021 | 17 | 0.050 |
Why?
| | Benchmarking | 1 | 2023 | 186 | 0.050 |
Why?
| | Protein Conformation, alpha-Helical | 1 | 2021 | 17 | 0.050 |
Why?
| | Furin | 1 | 2021 | 14 | 0.050 |
Why?
| | Asia | 1 | 2021 | 71 | 0.050 |
Why?
| | Granzymes | 1 | 2022 | 50 | 0.050 |
Why?
| | Nerve Net | 1 | 2024 | 256 | 0.050 |
Why?
| | Water Resources | 1 | 2021 | 8 | 0.050 |
Why?
| | Adipocytes | 1 | 2023 | 222 | 0.050 |
Why?
| | Africa | 1 | 2021 | 108 | 0.050 |
Why?
| | Immunity, Humoral | 1 | 2022 | 116 | 0.050 |
Why?
| | Molecular Docking Simulation | 1 | 2021 | 114 | 0.040 |
Why?
| | Epidemiological Monitoring | 1 | 2021 | 60 | 0.040 |
Why?
| | Adenosine Monophosphate | 1 | 2021 | 66 | 0.040 |
Why?
| | Linoleic Acid | 1 | 2021 | 43 | 0.040 |
Why?
| | Receptor-Like Protein Tyrosine Phosphatases, Class 8 | 1 | 2021 | 63 | 0.040 |
Why?
| | Arachidonic Acid | 1 | 2021 | 120 | 0.040 |
Why?
| | Cholesterol | 1 | 2023 | 410 | 0.040 |
Why?
| | Alanine | 1 | 2021 | 152 | 0.040 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2021 | 150 | 0.040 |
Why?
| | Europe | 1 | 2021 | 414 | 0.040 |
Why?
| | Glutamate Decarboxylase | 1 | 2021 | 170 | 0.040 |
Why?
| | Amino Acid Substitution | 1 | 2021 | 307 | 0.040 |
Why?
| | Sex Factors | 2 | 2019 | 2071 | 0.040 |
Why?
| | Docosahexaenoic Acids | 1 | 2021 | 84 | 0.040 |
Why?
| | Systems Biology | 1 | 2021 | 67 | 0.040 |
Why?
| | Skinfold Thickness | 1 | 2020 | 46 | 0.040 |
Why?
| | Interleukin-2 | 1 | 2022 | 455 | 0.040 |
Why?
| | Datasets as Topic | 1 | 2020 | 121 | 0.040 |
Why?
| | Swine | 1 | 2022 | 775 | 0.040 |
Why?
| | Particulate Matter | 1 | 2022 | 315 | 0.040 |
Why?
| | Workflow | 1 | 2021 | 165 | 0.040 |
Why?
| | Cattle | 1 | 2022 | 984 | 0.040 |
Why?
| | Nerve Tissue Proteins | 1 | 2023 | 596 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2020 | 110 | 0.040 |
Why?
| | Philippines | 1 | 2019 | 51 | 0.040 |
Why?
| | Colon | 1 | 2022 | 282 | 0.040 |
Why?
| | Pakistan | 1 | 2019 | 76 | 0.040 |
Why?
| | Finland | 1 | 2019 | 85 | 0.040 |
Why?
| | Bronchoscopy | 1 | 2020 | 223 | 0.040 |
Why?
| | In Vitro Techniques | 1 | 2021 | 1092 | 0.040 |
Why?
| | Chromatography, High Pressure Liquid | 1 | 2021 | 597 | 0.040 |
Why?
| | Water | 1 | 2022 | 460 | 0.040 |
Why?
| | Cigarette Smoking | 1 | 2020 | 101 | 0.040 |
Why?
| | Age of Onset | 1 | 2020 | 518 | 0.040 |
Why?
| | Gene Frequency | 1 | 2020 | 521 | 0.040 |
Why?
| | Cross-Sectional Studies | 2 | 2022 | 5472 | 0.040 |
Why?
| | Computer Graphics | 1 | 2018 | 42 | 0.040 |
Why?
| | Early Diagnosis | 1 | 2019 | 242 | 0.040 |
Why?
| | Interleukins | 1 | 2020 | 250 | 0.040 |
Why?
| | Environmental Pollution | 1 | 2018 | 20 | 0.040 |
Why?
| | Diabetes Mellitus, Type 2 | 2 | 2023 | 2531 | 0.040 |
Why?
| | Community-Acquired Infections | 1 | 2020 | 174 | 0.040 |
Why?
| | Leptin | 1 | 2019 | 236 | 0.040 |
Why?
| | Pedigree | 1 | 2019 | 514 | 0.040 |
Why?
| | Adaptor Proteins, Vesicular Transport | 1 | 2018 | 45 | 0.040 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2017 | 33 | 0.030 |
Why?
| | Breast Feeding | 1 | 2021 | 440 | 0.030 |
Why?
| | Maternal Health | 1 | 2018 | 49 | 0.030 |
Why?
| | Cell Transformation, Viral | 1 | 2017 | 25 | 0.030 |
Why?
| | Evolution, Molecular | 1 | 2021 | 493 | 0.030 |
Why?
| | Collagen | 1 | 2020 | 452 | 0.030 |
Why?
| | United States | 3 | 2021 | 14841 | 0.030 |
Why?
| | Epistasis, Genetic | 1 | 2017 | 70 | 0.030 |
Why?
| | Caprylates | 1 | 2017 | 25 | 0.030 |
Why?
| | Umbilical Cord | 1 | 2017 | 85 | 0.030 |
Why?
| | Time Factors | 2 | 2021 | 6828 | 0.030 |
Why?
| | TOR Serine-Threonine Kinases | 1 | 2020 | 412 | 0.030 |
Why?
| | Gambia | 1 | 2016 | 14 | 0.030 |
Why?
| | Muscle Development | 1 | 2017 | 111 | 0.030 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 434 | 0.030 |
Why?
| | THP-1 Cells | 1 | 2016 | 22 | 0.030 |
Why?
| | Lod Score | 1 | 2016 | 67 | 0.030 |
Why?
| | Rats, Inbred SHR | 1 | 2016 | 45 | 0.030 |
Why?
| | Regulon | 1 | 2016 | 36 | 0.030 |
Why?
| | Immunity, Innate | 1 | 2022 | 828 | 0.030 |
Why?
| | Actins | 1 | 2018 | 416 | 0.030 |
Why?
| | Nitrogen Oxides | 1 | 2016 | 55 | 0.030 |
Why?
| | ABO Blood-Group System | 1 | 2016 | 51 | 0.030 |
Why?
| | Child Health | 1 | 2018 | 154 | 0.030 |
Why?
| | Granuloma | 1 | 2016 | 92 | 0.030 |
Why?
| | Antigen Presentation | 1 | 2017 | 218 | 0.030 |
Why?
| | Logistic Models | 1 | 2021 | 2074 | 0.030 |
Why?
| | Fetal Development | 1 | 2019 | 296 | 0.030 |
Why?
| | Insulin Resistance | 1 | 2024 | 1208 | 0.030 |
Why?
| | Linkage Disequilibrium | 1 | 2016 | 268 | 0.030 |
Why?
| | Follicular Phase | 1 | 2015 | 39 | 0.030 |
Why?
| | Ovulation | 1 | 2015 | 40 | 0.030 |
Why?
| | CD4-Positive T-Lymphocytes | 1 | 2022 | 1091 | 0.030 |
Why?
| | PAX3 Transcription Factor | 1 | 2015 | 17 | 0.030 |
Why?
| | Caenorhabditis elegans Proteins | 1 | 2017 | 199 | 0.030 |
Why?
| | Mice, Congenic | 1 | 2015 | 22 | 0.030 |
Why?
| | Molecular Sequence Annotation | 1 | 2015 | 99 | 0.030 |
Why?
| | Paired Box Transcription Factors | 1 | 2015 | 46 | 0.030 |
Why?
| | Prevalence | 1 | 2022 | 2734 | 0.030 |
Why?
| | Bacteria | 1 | 2022 | 858 | 0.030 |
Why?
| | Hair Follicle | 1 | 2015 | 46 | 0.030 |
Why?
| | Intramolecular Oxidoreductases | 1 | 2015 | 68 | 0.030 |
Why?
| | Immune System | 1 | 2016 | 177 | 0.030 |
Why?
| | Latent Tuberculosis | 1 | 2015 | 69 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-kit | 1 | 2015 | 67 | 0.030 |
Why?
| | Mortality | 1 | 2017 | 362 | 0.030 |
Why?
| | Monocytes | 1 | 2017 | 563 | 0.030 |
Why?
| | Heart | 1 | 2018 | 655 | 0.030 |
Why?
| | Breeding | 1 | 2014 | 64 | 0.030 |
Why?
| | Gastroesophageal Reflux | 1 | 2017 | 234 | 0.030 |
Why?
| | Fetus | 1 | 2019 | 806 | 0.030 |
Why?
| | Protein Kinases | 1 | 2016 | 319 | 0.030 |
Why?
| | Epidermis | 1 | 2015 | 157 | 0.030 |
Why?
| | Caenorhabditis elegans | 1 | 2017 | 306 | 0.030 |
Why?
| | Diet, High-Fat | 1 | 2015 | 247 | 0.030 |
Why?
| | Monophenol Monooxygenase | 1 | 2013 | 8 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2017 | 1060 | 0.030 |
Why?
| | Microscopy, Phase-Contrast | 1 | 2013 | 18 | 0.030 |
Why?
| | Annexin A5 | 1 | 2013 | 25 | 0.030 |
Why?
| | Melanins | 1 | 2013 | 18 | 0.030 |
Why?
| | Spectrophotometry | 1 | 2013 | 61 | 0.030 |
Why?
| | Education | 1 | 2013 | 108 | 0.030 |
Why?
| | Catalase | 1 | 2013 | 130 | 0.030 |
Why?
| | Pilot Projects | 1 | 2018 | 1710 | 0.030 |
Why?
| | Administration, Topical | 1 | 2013 | 151 | 0.030 |
Why?
| | Blood Glucose | 1 | 2023 | 2186 | 0.020 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2013 | 385 | 0.020 |
Why?
| | Statistics, Nonparametric | 1 | 2013 | 431 | 0.020 |
Why?
| | Promoter Regions, Genetic | 1 | 2017 | 1250 | 0.020 |
Why?
| | Real-Time Polymerase Chain Reaction | 1 | 2013 | 346 | 0.020 |
Why?
| | Structure-Activity Relationship | 1 | 2013 | 570 | 0.020 |
Why?
| | Neutrophils | 1 | 2017 | 1238 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2014 | 658 | 0.020 |
Why?
| | Urinary Bladder Neoplasms | 1 | 2014 | 252 | 0.020 |
Why?
| | GTP-Binding Protein beta Subunits | 1 | 2010 | 11 | 0.020 |
Why?
| | Receptors, GABA | 1 | 2010 | 14 | 0.020 |
Why?
| | Thermosensing | 1 | 2010 | 12 | 0.020 |
Why?
| | Superoxide Dismutase | 1 | 2013 | 346 | 0.020 |
Why?
| | Software Design | 1 | 2010 | 24 | 0.020 |
Why?
| | Membrane Proteins | 1 | 2017 | 1164 | 0.020 |
Why?
| | Genetics, Behavioral | 1 | 2010 | 36 | 0.020 |
Why?
| | Crosses, Genetic | 1 | 2010 | 137 | 0.020 |
Why?
| | Cell Movement | 1 | 2015 | 967 | 0.020 |
Why?
| | Bacterial Proteins | 1 | 2016 | 879 | 0.020 |
Why?
| | Embryo, Nonmammalian | 1 | 2010 | 167 | 0.020 |
Why?
| | Organ Specificity | 1 | 2010 | 305 | 0.020 |
Why?
| | Endothelium, Vascular | 1 | 2016 | 927 | 0.020 |
Why?
| | Cell Survival | 1 | 2013 | 1120 | 0.020 |
Why?
| | Colorado | 1 | 2020 | 4565 | 0.020 |
Why?
| | Models, Biological | 1 | 2017 | 1783 | 0.020 |
Why?
| | Rats, Inbred Strains | 1 | 2009 | 362 | 0.020 |
Why?
| | Antioxidants | 1 | 2013 | 584 | 0.020 |
Why?
| | Brain Chemistry | 1 | 2009 | 117 | 0.020 |
Why?
| | Hypoxia | 1 | 2016 | 1112 | 0.020 |
Why?
| | gamma-Aminobutyric Acid | 1 | 2010 | 198 | 0.020 |
Why?
| | Macrophages | 1 | 2016 | 1547 | 0.020 |
Why?
| | Models, Molecular | 1 | 2013 | 1570 | 0.020 |
Why?
| | Histones | 1 | 2013 | 636 | 0.020 |
Why?
| | Surveys and Questionnaires | 1 | 2020 | 5778 | 0.020 |
Why?
| | Brain Mapping | 1 | 2010 | 503 | 0.020 |
Why?
| | Curriculum | 1 | 2013 | 992 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2014 | 3412 | 0.020 |
Why?
| | Cells, Cultured | 1 | 2013 | 4193 | 0.010 |
Why?
| | Antineoplastic Agents | 1 | 2014 | 2129 | 0.010 |
Why?
| | Disease Models, Animal | 1 | 2009 | 4295 | 0.010 |
Why?
| | Retrospective Studies | 1 | 2017 | 15657 | 0.010 |
Why?
|
|
Kechris's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|